Moriwaki, Toshikazu http://orcid.org/0000-0001-7702-122X
Sakai, Yoshinori
Ishida, Hiroyasu
Yamamoto, Yoshiyuki
Endo, Shinji
Kuramochi, Hideaki
Sato, Mikio
Hatachi, Yukimasa
Bando, Yoshiaki
Maeba, Takashi
Ikezawa, Kazuto
Shimada, Mitsuo
Amagai, Kenji
Morimoto, Masamitsu
Kobayashi, Kazuma
Tsuji, Akihito
Nishina, Tomohiro
Hyodo, Ichinosuke
Funding for this research was provided by:
NPO Tsukuba Cancer Clinical Trial Group
Article History
Received: 28 January 2019
Accepted: 4 May 2019
First Online: 14 May 2019
Compliance with ethical standards
:
: MS received a research funding from Chugai, Taiho, CSL Behring, MSD, Astelllas, AbbVie, Eisai, Ono, TSUMURA, Coviklen Japan, Johnson&Johnson, Takeda, Novartis, Bayer Yakuhin, and Merck Serono; KA received research funding from Taiho, Hisamitsu, and MSD; AT received honoraria from Chugai and Taiho; TN received research funding from Taiho; IH received honoraria and research funding from Taiho and Chugai. All other authors declare no potential conflicts of interest.